Diffuse large B cell lymphoma: variants, subgroups and subtypes/entities

Maja Perunicic-Jovanovic
Maja Perunicic-Jovanovic

Published: 01.12.2011.

Biochemistry

Volume 28, Issue 2 (2012)

pp. 489-493;

https://doi.org/10.5937/matmed1202489p

Abstract

Keywords

References

1.
Campo ., Harris E, N, E. 2008;
2.
E. The 2008 WHO classification of lymphomas: implication for clinical practice and translational research. Hematology am soc Hematol Educ Program. 2009;523–31.
3.
Pileri W, Ph E, Marafioti T, Tzankov, Leoncini L, Falini B, et al. diffuse large B-cell lymphoma: one or more entities? Present controversies and possible tools for its subklassification. Histopathology. 2002;482–509.
4.
Garcia F, Md ;, Md H. Best practices in Contemporary diagnostic immunohistochemistry. Panel approach to Hematolymphoid Proliferations. arch Pathol Lab Med. 2009;756–65.
5.
Higgins R, Md; Jennofer E, Blankenship, Md ;, Marsha C, Kinney M. application of Immunohistochemistry in the diagnosis of Non-Hodgkin and Hodgkin Lymphoma. arch Pathol Lab Med. 2008;441–61.
6.
Is L, Morgensztern D. Prognostic biomarkers in diffuse large B-cell lymphoma. Clin Oncol. 2006;995–1007.
7.
De Yong D, Chhanabhai M, Gaulard P, Klapper W, Lee. Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as perequisite for broad clinical applications-a study from Lunenburg Lymphoma Biomarker Consortium. Clin Oncol. 2007;805–12.
8.
Hans C, Weisenburger Dd, Greiner T, Gascoyne, Ott G. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;275–82.
9.
Gustaaf W, Van Imhoff. Prognostic Impact of Germinal Center-associated Proteins and Chromosomal Breakpoints in poor-risk diffuse Large B-Cell Lymphoma. journal of Clinical Oncology. 2006;4135–42.
10.
. Pittaluga s.:aggressive B-Cell Lymphomas: a review of New and Old Entities in the WHO Classification. Hematology am soc Hematol Educ Program. 2011;506–14.
11.
Biasoli I, Morais J, Milito C, Land M. Cd10 and Bcl-2 expression combined with the International Prognostic index can identify subgroups of patients with diffuse large-cell lymphoma with very good or very poor prognoses. Histopathology. 2005;(3):328–33.

Citation

Copyright

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Partners